KOSPI · Healthcare · ₩374B
₩3,750+2.46%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Short Volume 4.7% · as of 26.10.27
Among 97 제약 peers
Quarterly Revenue Growth
“매출 성장은 이어졌고 이제 이익으로 연결되는 힘을 볼 때예요.”
In the company's words · 2026 2분기 filing